Document Detail

Advances in the treatment of Hodgkin lymphoma.
MedLine Citation:
PMID:  23054655     Owner:  NLM     Status:  Publisher    
In the past decades, Hodgkin lymphoma (HL) has turned from an incurable disease to one with the most favorable prognosis among adult malignancies. This is due to the introduction of effective multi-agent chemotherapy and the optimization of radiation techniques. At present, 80-90 % of patients achieve long-term remission when receiving appropriate first-line treatment. Even in case of relapse, up to 50 % can be successfully salvaged with high-dose chemotherapy and autologous stem cell transplantation. Thus, current studies do not necessarily aim at increasing treatment efficacy but rather focus on a possible reduction of acute and late toxicity by decreasing treatment intensity if possible. One promising strategy to spare therapy in good-risk patients is early response-adapted treatment stratification according to the result of interim positron emission tomography. The evaluation of novel drugs and the optimization of treatment for elderly HL patients and those with nodular lymphocyte-predominant HL are further aspects that are currently being addressed in ongoing trials. This review will give an overview on more recent clinical trials and discuss possible future strategies for the treatment of HL.
Dennis A Eichenauer; Andreas Engert
Related Documents :
23423445 - Pam50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer.
24673265 - Brief overview of selected approaches in targeting pancreatic adenocarcinoma.
7541335 - Lenograstim. a review of its pharmacological properties and therapeutic efficacy in neu...
16803675 - Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating fa...
19851525 - Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer.
127655 - A clinical trial of chemotherapy and raji immunotherapy in advanced acute lymphatic leu...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-11
Journal Detail:
Title:  International journal of hematology     Volume:  -     ISSN:  1865-3774     ISO Abbreviation:  Int. J. Hematol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111627     Medline TA:  Int J Hematol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
First Department of Internal Medicine, University Hospital Cologne, 50937, Cologne, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epigenetic aspects of MDS and its molecular targeted therapy.
Next Document:  Young research investigators honored at the 2012 Gordon Research Conference on photosynthesis.